These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 16186053

  • 41. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK, Tromp J, Tay WT, Anand I, Ouwerkerk W, Chopra V, Wander GS, Yap JJ, MacDonald MR, Xu CF, Chia YM, Shimizu W, ASIAN-HF investigators, Richards AM, Voors A, Lam CS.
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [Abstract] [Full Text] [Related]

  • 42. Enhancing quality of heart failure care in managed Medicare and Medicaid in North Carolina: results of the North Carolina Achieving Cardiac Excellence (NC ACE) Project.
    Goff DC, Massing MW, Bertoni AG, Davis J, Ambrosius WT, McArdle J, Duren-Winfield V, Sueta CA, Croft JB.
    Am Heart J; 2005 Oct; 150(4):717-24. PubMed ID: 16209973
    [Abstract] [Full Text] [Related]

  • 43. Effects of treatment recommendations and specialist intervention on care provided by primary care physicians to patients with myocardial infarction or heart failure.
    Guadagnoli E, Normand SL, DiSalvo TG, Palmer RH, McNeil BJ.
    Am J Med; 2004 Sep 15; 117(6):371-9. PubMed ID: 15380493
    [Abstract] [Full Text] [Related]

  • 44. Effect of beta blocker therapy on survival of patients with heart failure and preserved systolic function following hospitalization with acute decompensated heart failure.
    Nevzorov R, Porath A, Henkin Y, Kobal SL, Jotkowitz A, Novack V.
    Eur J Intern Med; 2012 Jun 15; 23(4):374-8. PubMed ID: 22560389
    [Abstract] [Full Text] [Related]

  • 45. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM, Lokhnygina Y, Velazquez EJ, McMurray JJ, Leimberger JD, Lewis EF, Diaz R, Murin J, Pfeffer MA.
    Am J Cardiol; 2009 Jul 15; 104(2):151-7. PubMed ID: 19576338
    [Abstract] [Full Text] [Related]

  • 46. Relation between serum sodium levels and prognosis in outpatients with chronic heart failure: neutral effect of treatment with beta-blockers and angiotensin-converting enzyme inhibitors: data from the Italian Network on Congestive Heart Failure (IN-CHF database).
    Baldasseroni S, Urso R, Orso F, Bianchini BP, Carbonieri E, Cirò A, Gonzini L, Leonardi G, Marchionni N, Maggioni AP, IN-CHF Investigators.
    J Cardiovasc Med (Hagerstown); 2011 Oct 15; 12(10):723-31. PubMed ID: 21873881
    [Abstract] [Full Text] [Related]

  • 47. Time trends in the use of beta-blockers and other pharmacotherapies in older adults with congestive heart failure.
    Smith NL, Chan JD, Rea TD, Wiggins KL, Gottdiener JS, Lumley T, Psaty BM.
    Am Heart J; 2004 Oct 15; 148(4):710-7. PubMed ID: 15459605
    [Abstract] [Full Text] [Related]

  • 48. Association of beta-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS).
    Chan JD, Rea TD, Smith NL, Siscovick D, Heckbert SR, Lumley T, Chaves P, Furberg CD, Kuller L, Psaty BM.
    Am Heart J; 2005 Sep 15; 150(3):464-70. PubMed ID: 16169325
    [Abstract] [Full Text] [Related]

  • 49. Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
    Jost A, Rauch B, Hochadel M, Winkler R, Schneider S, Jacobs M, Kilkowski C, Kilkowski A, Lorenz H, Muth K, Zugck C, Remppis A, Haass M, Senges J, HELUMA study group.
    Eur Heart J; 2005 Dec 15; 26(24):2689-97. PubMed ID: 16183697
    [Abstract] [Full Text] [Related]

  • 50. [Pharmacological therapy of chronic heart failure in the elderly].
    Sabbadini G, Di Lenarda A, Metra M, Nodari S, Moretti M, Brentana L, Dei Cas L, Sinagra G.
    Ital Heart J; 2004 Dec 15; 5 Suppl 10():37S-51S. PubMed ID: 15712511
    [Abstract] [Full Text] [Related]

  • 51. Intensity and focus of heart failure disease management after hospital discharge.
    Shah MR, Flavell CM, Weintraub JR, Young MA, Hasselblad V, Fang JC, Nohria A, Lewis EF, Givertz MM, Mudge G, Stevenson LW.
    Am Heart J; 2005 Apr 15; 149(4):715-21. PubMed ID: 15990758
    [Abstract] [Full Text] [Related]

  • 52. Prescription patterns of pharmacological agents for left ventricular systolic dysfunction among hemodialysis patients.
    Roy P, Bouchard J, Amyot R, Madore F.
    Am J Kidney Dis; 2006 Oct 15; 48(4):645-51. PubMed ID: 16997061
    [Abstract] [Full Text] [Related]

  • 53. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.
    Cole JA, Norman H, Weatherby LB, Walker AM.
    Pharmacotherapy; 2006 Aug 15; 26(8):1157-64. PubMed ID: 16863491
    [Abstract] [Full Text] [Related]

  • 54. Quality of heart failure care in managed Medicare and Medicaid patients in North Carolina.
    Bertoni AG, Duren-Winfield V, Ambrosius WT, McArdle J, Sueta CA, Massing MW, Peacock S, Davis J, Croft JB, Goff DC.
    Am J Cardiol; 2004 Mar 15; 93(6):714-8. PubMed ID: 15019875
    [Abstract] [Full Text] [Related]

  • 55. Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000.
    Lee DS, Mamdani MM, Austin PC, Gong Y, Liu PP, Rouleau JL, Tu JV.
    Am J Med; 2004 May 01; 116(9):581-9. PubMed ID: 15093753
    [Abstract] [Full Text] [Related]

  • 56. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
    Güder G, Störk S, Gelbrich G, Brenner S, Deubner N, Morbach C, Wallenborn J, Berliner D, Ertl G, Angermann CE.
    Eur J Heart Fail; 2015 Apr 01; 17(4):442-52. PubMed ID: 25727879
    [Abstract] [Full Text] [Related]

  • 57. Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure.
    Ansari M, Shlipak MG, Heidenreich PA, Van Ostaeyen D, Pohl EC, Browner WS, Massie BM.
    Circulation; 2003 Jun 10; 107(22):2799-804. PubMed ID: 12756157
    [Abstract] [Full Text] [Related]

  • 58. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS, Bajorek BV.
    J Clin Pharm Ther; 2008 Dec 10; 33(6):591-601. PubMed ID: 19138236
    [Abstract] [Full Text] [Related]

  • 59. Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure.
    Tribouilloy C, Rusinaru D, Leborgne L, Peltier M, Massy Z, Slama M.
    Am J Cardiol; 2008 Mar 01; 101(5):639-44. PubMed ID: 18308013
    [Abstract] [Full Text] [Related]

  • 60. Comparison of the outcome in men and women with chronic heart failure.
    De Feo S, Opasich C.
    Ital Heart J; 2003 Aug 01; 4(8):511-3. PubMed ID: 14564974
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.